Chemotherapy With Erlotinib or Chemotherapy Alone in Advanced Non-Small Cell Lung Cancer With Acquired Resistance to EGFR Tyrosine Kinase Inhibitors

PURPOSE. Epidermal growth factor receptor (EGFR)-mutant non-small cell lung cancer has an oncogene-addicted biology that confers sensitivity to EGFR tyrosine kinase inhibitors (TKIs). Published data suggest that EGFR addiction persists after development of TKI acquired resistance, leading many clini...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Goldberg, Sarah B., Oxnard, Geoffrey R., Digumarthy, Subba, Muzikansky, Alona, Jackman, David M., Lennes, Inga T., Sequist, Lecia V.
Format: Artigo
Langue:Inglês
Publié: AlphaMed Press 2013
Sujets:
Lung Cancer
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC3825307/
https://ncbi.nlm.nih.gov/pubmed/24072220
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2013-0168
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires